Key result
Computerized warfarin clinical decision support is linked to improved TTR and ~59% fewer VTE events.
Why the study?
An explicit approach using computerized clinical decision support to improve warfarin dose adjustment and management was evaluated for quality metrics in a large health care system.
Does computerized clinical decision support improve time in therapeutic range and clinical outcomes in chronically anticoagulated patients?
Cohort (n=2,591)
Does computerized clinical decision support improve time in therapeutic range and clinical outcomes in chronically anticoagulated patients?
Absolute Event Rate: 65.13% vs 63.99%
p-value: p=.04
Computerized clinical decision support for warfarin management modestly improves time in therapeutic range and reduces thromboembolism, but may increase major bleeding risk.
CDS may improve TTR with warfarin; leaves open whether randomized trials confirm system-wide gains.
BACKGROUND: An explicit approach to warfarin dose adjustment using computerized clinical decision support (CDS) improves warfarin management. We report metrics of quality for warfarin management before and after implementation of CDS in a large health care system. METHODS: A total of 2591 chronically anticoagulated patients were eligible for inclusion. We compared interpatient time in therapeutic range (TTR) and international normalized ratio (INR) variability before and after implementation of CDS. We report outcomes of major bleeding, thrombosis, and health care utilization. RESULTS: Implementation of CDS significantly improved TTR (from 63.99% to 65.13%; P = .04) and reduced out-of-range INRs (from 42.39% to 39.97%; P < .001). Venous thromboembolism (relative risk [RR] 0.41; P < .001) emergency department utilization (RR 0.62; P < .001), and hospitalization (RR 0.62; P < .001) were reduced after CDS implementation. Major hemorrhage was more frequent after CDS implementation (RR 1.42; P = .01). CONCLUSION: The CDS warfarin management was associated with improved TTR and decreased INR variability in a large cohort of chronically anticoagulated patients. Clinically relevant outcomes were broadly improved, although more bleeding events were observed.
No takes yet. Share an insight, caveat, or question.
Woller et al. (2014) conducted a cohort in chronically anticoagulated patients (n=2,591). Computerized clinical decision support (CDS) vs. Before implementation of CDS was evaluated on interpatient time in therapeutic range (TTR) (p=.04). Computerized clinical decision support for warfarin management improved time in therapeutic range from 63.99% to 65.13% (P=0.04) and reduced venous thromboembolism (RR 0.41; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: